Boston Scientific has completed enrolling first patient in REPRISE II clinical trial, designed to assess the safety and efficacy of the Lotus Valve system in minimizing aortic regurgitation (leaking). The Lotus Valve system, which the ...
Tags: Boston Scientific, first patient, REPRISE II clinical trial
Spacelabs Healthcare is presenting its anesthesia delivery system, patient monitoring and connectivity, and diagnostic cardiology solutions at MEDICA, being held at Dusseldorf, Germany from 14-17 November 2012. The ARKON anesthesia ...
Tags: Spacelabs, anesthesia delivery system, ARKON, patient care solutions
Medtronic has introduced the Endurant II AAA Stent Graft system in the US, following the US Food and Drug Administration's (FDA) approval. The Endurant II AAA Stent Graft system is designed for the treatment of abdominal aortic aneurysms ...
Tags: Medtronic, Endurant II AAA Stent Graft system, FDA, EVAR
Cook Medical has received the US Food and Drug Administration (FDA) approval for its new Evolution colonic controlled-release stent. The new stent design features Kink-resistant flexor technology-based delivery system for pushability ...
Tags: Cook Medical, FDA, medical technology
Delcath Systems has submitted its proprietary chemosaturation delivery system's new drug application (NDA) to the US Food and Drug Administration (FDA). The application includes the use of chemosaturation system along with melphalan ...
Tags: FDA, NDA, medical application
Medline Industries has entered into a two-year agreement to distribute MemorialCare Health System's, a not-for-profit integrated delivery system, medical and surgical supplies. Under the agreement, which is expected to begin from 1 ...
pSivida, a developer of sustained release drug delivery products, has entered into an agreement with a biopharmaceutical company for the evaluation of its Tethadur protein/antibody delivery technology. Designed for use in the field of ...
Svelte Medical Systems has commenced First Assessment of the Acrobat Stenting Technique European Post-Market Registry (FAASTER) study. The multi-center registry study, which will enroll up to 1,500 patients, is designed to evaluate the ...
Tags: Svelte Medical Systems, FAASTER, FAASTER study, registry study
Edwards Lifesciences is set to begin clinical trial to assess its Intuity valve system, following an investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA). The prospective, multi-center study, ...
Tags: clinical trial, Intuity valve system, FDA
Flexible Stenting Solutions has received CE mark approval for its FlexSten Iliac Self Expanding Stent system for the treatment of symptomatic atherosclerotic disease of the common and/or external iliac arteries. The FlexStent Iliac Stent ...
Tags: Flexible Stenting Solutions, FlexSten Iliac Self Expanding Stent system
InSite Vision has launched a new DuraSite 2 drug delivery system, designed to deliver ophthalmic therapeutics. DuraSite 2, which is based on InSite DuraSite technology, incorporates cataract surgery drug, ketorolac, a non-steroidal ...
Tags: InSite, Ophthalmic Drug Delivery System, ophthalmic therapeutics
Greyson International has received a Notice of Allowance from the US Patent and Trademark Office for its Trilexon delivery system technology. The new system technology allows active ingredients to work for a longer period of time than ...
Tags: US Patent, Trilexon Delivery System, clinical technology
Beacon Endoscopic has introduced the BNX system for use in endoscopic ultrasound (EUS) and endoscopic bronchial ultrasound procedures. The BNX system includes a delivery system designed for loading and unloading fine needle aspiration ...
Tags: BNX Delivery System, clinical technology, clinical application
GeNO has obtained a clearance for its inhaled nitric oxide (NO) delivery system, GeNOsyl MV-1000, from the US Food and Drug Administration (FDA). GeNOsyl MV-1000 system, which incorporates a primary delivery system, a backup system, ...
Tags: FDA, inhaled nitric oxide delivery system, clinical product, GeNO
GeNO has received four additional US patents for its proprietary nitric oxide (NO) generation chemistry and delivery technology. The patent No. 8,211,368 describes the conversion of nitrogen dioxide (NO2) to NO where NO2 is stored as ...
Tags: US patent, clinical technology, clinical research, GeNO